Skip to content

Fevery-Dewitte

Active Private limited companyfounded 2005active for 20 yearsZuidzandstraat 1, 8000 BrugesKBO/BCE: BE 0878.046.473 subsidiary of

Lifetime

20 annual accounts with figures on one time axis
peak of €344,318 in 2025
€344,318▲ 9.0%
peak of €124,456 in 2025
€124,456▲ 8.2%
peak of €550,211 in 2020
€392,551▼ 7.8%
€464,189▲ 63.5%
peak of 3.1 FTE in 2023
1.9 FTEunchanged
Board2 names since 2006
2 directors and 1 other
Owners
99.6%
Documentsfilings and deeds
31-07-2026on the last day
2025abbreviated format
Dividend €100,000Debts from €283,988 to €464,189

Key points

from the 2025 annual accounts

Equity

€392,551 ▼ 7.8%
425,5952024+124,456Profit-100,000Dividend-57,500Other392,5512025

Fevery-Dewitte paid out €100,000 in dividends. That is 80% of the 2025 profit.

Debts

€464,189 ▲ 63.5%
Other debts
+50,000
Taxes and wages
+5,995
The rest
+124,207

Debts rose by €180,201 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2019 accounts came in latest, 17 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as Fevery-Dewitte has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for Fevery-Dewitte. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-01-2006
Manager, , since 31-05-2014
  • 99.6%score equity €1.2m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

New establishment in Bruges Apotheek De Braamberg, Braambergstraat 23
Registered in the Peppol Directory Reachable for e-invoices through 0208:0878046473
changes role from statutory manager to director resigns as manager · “Het verwerven van participaties in eender welke vorm in alle bestaande of op te richten rechtspersonen en…” (deed in Dutch) · General meeting of 20-12-2023 · Gazette deed
resigns as manager General meeting of 05-01-2019 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
Fevery-Dewitte Bruges €0.9m €344,318 45.8% 1.9
APOTHEEK CHARLOTTE RAES Harelbeke €0.8m €389,756 42.2% 2
Apotheek Reynders Ostend €0.9m €389,372 6.9% 1.8
DISTEPHAR Zedelgem €1.0m €296,030 22.2% 1.9
APOTHEEK SABINE DESIMPEL Moorslede €1.0m €328,806 70.3% 1.5
Apotheek Soetkin Op De Beeck Blankenberge €0.9m €338,847 36.8% 1.8
APOTHEEK DECOUTERE KATRIEN Wevelgem €0.9m €332,498 80.0% 1.4

These companies have the same main activity as Fevery-Dewitte: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €843,000 and €1m, founded between 2006 and 2010.

Official details

Source: KBO
Status
Active since 20-12-2005Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment units
2.152.851.0588000 Bruges, since 11-04-2006
2.388.697.3538000 Bruges, since 04-05-2026
Financial year end
31 December
Peppol
Reachable since 04-06-2024
Company details

Annual accounts 2025

≈ €1.2mestimated
€856,740▲ 20.7%
Employeeson 31-12-2025
3=
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on Fevery-Dewitte

Fevery-Dewitte files the abbreviated format. That format states no turnover. The gross margin rose from €177,621 in 2006 to €344,318 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Fevery-Dewitte

What is the company number of Fevery-Dewitte?
The company number of Fevery-Dewitte is 0878.046.473. The VAT number is the same number with BE in front: BE 0878.046.473.
Where is Fevery-Dewitte based?
The registered office is at Zuidzandstraat 1, 8000 Bruges.Company details
What does Fevery-Dewitte do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Fevery-Dewitte?
Fevery-Dewitte is a private limited company (BV).
When was Fevery-Dewitte founded?
Fevery-Dewitte was founded on 20-12-2005.
Is Fevery-Dewitte still active?
Yes, Fevery-Dewitte is an active enterprise in the KBO register.
How many employees does Fevery-Dewitte have?
Fevery-Dewitte had an average of 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Fevery-Dewitte fall under?
In its 2025 annual accounts, Fevery-Dewitte states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Fevery-Dewitte?
The turnover in financial year 2025 is about €1.2m. This figure is estimated from the gross margin of €344,318 and 42 comparable companies (NACE 477). It probably lies between €930,000 and €1.6m.
Is Fevery-Dewitte profitable?
In financial year 2025, Fevery-Dewitte made a profit of €124,456.
Where can I find the annual accounts of Fevery-Dewitte?
Fevery-Dewitte filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Fevery-Dewitte due?
Fevery-Dewitte must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.